UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
UAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
UAB continues to improve maternal and infant health as the only university to be a member of all three NIH perinatal networks.
The third annual Heart + Sole 5K and Kids’ Run will be on Saturday, Aug. 20, at Crestline Elementary. Funds raised will benefit Equal Access Birmingham, the School of Medicine student-run free clinic, which provides education and health care to Birmingham’s uninsured and underserved.
Written by Jeff Hansen
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.